Brandon is a partner in McKinsey’s Washington, DC, office and a leader in the Life Sciences Practice. For the past decade, Brandon has focused on biopharma research and development, working with both public-sector clients and private-sector sponsors on issues across the R&D value chain. Brandon serves clients on a wide range of topics related to R&D optimization, with a particular focus on drug safety, regulatory affairs, and clinical development.
In addition to his focus on pharmaceuticals and medical products, Brandon helps lead McKinsey’s work with medical-products regulators on a global basis. He brings deep expertise on a wide range of organization topics.
Prior to joining McKinsey, Brandon worked in life-sciences venture capital, where he invested in and built businesses focused on oncology, immunology, and orphan diseases.